Gilead Sciences: Executive Changes are ‘Negative Signals’ But…

Gilead Sciences ( GILD ) yesterday announced an executive shakeup that saw a new chief operating officer and executive vice president of strategy join the firm. Leerink's Geoffrey Porges calls the moves "negative signals near term," but "reassuring long term." He explains why:
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.